Showing posts from tagged with: palb2

Pathway Genomics Announces Commitment to Free the Data Movement at NSGC Conference

Posted on 09/18/2014 in News, Press Releases

SAN DIEGO, CASeptember 18, 2014 – Pathway Genomics Corporation, a global clinical genetic testing company, announced today at the National Society of Genetic Counselors’ 33rd Annual Education Conference its commitment to Free the Data, a movement dedicated to open access to genetic data and collaboration through information sharing.  

Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with PALB2

Posted on 09/10/2014 in News, Press Releases

SAN DIEGO, CASeptember 10. 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueTM High Risk Panel, a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.